|
|
Article: FDA Approves CLARINEX-D(R) 12 HOUR (desloratadine 2.5mg/pseudoephedrine 120mg) Tablet Prescription Antihistamine with Decongestant for Seasonal Allergy Sufferers.
- Article from:
- PR Newswire
- Article date:
- February 1, 2006
CopyrightCOPYRIGHT 2006 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
New Formulation Provides Powerful Relief Of Seasonal Allergy Symptoms, Including Nasal Congestion
KENILWORTH, N.J., Feb. 1 /PRNewswire/ -- Schering-Plough Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved CLARINEX-D(R) 12 HOUR (desloratadine 2.5 mg and pseudoephedrine sulfate, USP 120 mg) Extended Release Tablets for the relief of nasal and non- nasal symptoms of seasonal allergic rhinitis (outdoor allergies), including nasal congestion, in patients 12 years of age and older.
CLARINEX-D 12 HOUR will be available nationwide in March 2006, in time for the spring allergy season. The new treatment option addresses ...